Stroke, Vol 23, 1733-1742, Copyright © 1992 by American Heart Association
J Knop, A Thie, C Fuchs, G Siepmann and H Zeumer
BACKGROUND AND PURPOSE: Insufficiency of collateral supply may lead to
low-flow infarcts in severe occlusive cerebrovascular disease. The aim of
this study was to evaluate the feasibility of technetium-99m-labeled
hexamethylpropyleneamine oxime (99mTc-HMPAO) single-photon emission
computed tomography (SPECT) to assess hemodynamic compromise in the
anterior circulation. METHODS: Cerebral blood flow before and after 1 g
acetazolamide was analyzed by 99mTc-HMPAO-SPECT in 21 symptomatic patients
with documented extracranial obstructions. SPECT findings were correlated
with the results of angiography, transcranial Doppler sonography, and
computed tomographic scan. RESULTS: The acetazolamide- induced increase of
cerebral blood flow could be reliably monitored by increase of cerebral
99mTc-HMPAO uptake, which varied between 11.4% and 47.6% in the
less-affected hemisphere. Increment of hemispheric side-to- side asymmetry
of tracer uptake after drug challenge revealed significant restriction of
regional vasoreactivity in 11 patients. Agreement in assessing hemodynamic
compromise was reached in 81% of patients with ophthalmic artery
collaterals on angiography (p < 0.001), in 76% with low-flow infarcts on
computed tomographic scan (p < 0.01), and in 91% with markedly reduced
flow velocities on transcranial Doppler (p < 0.0001). One patient
developed a low-flow infarct in the area predicted by SPECT during follow
up. CONCLUSIONS: We conclude that 99mTc-HMPAO-SPECT with acetazolamide
challenge is a useful method for assessment of the adequacy of hemispheric
collateral pathways in patients with severe occlusive cerebrovascular
disease.
ARTICLES
99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease
Department of Nuclear Medicine, University Hospital Eppendorf, Hamburg, FRG.
This article has been cited by other articles:
![]() |
S. Yamamoto, M. Watanabe, T. Uematsu, K. Takasawa, M. Nukata, and N. Kinoshita Correlation of Angiographic Circulation Time and Cerebrovascular Reserve by Acetazolamide-Challenged Single Photon Emission CT AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Catafau Brain SPECT in Clinical Practice. Part I: Perfusion J. Nucl. Med., February 1, 2001; 42(2): 259 - 271. [Abstract] [Full Text] |
||||
![]() |
M. Wiart, Y. Berthezene, P. Adeleine, P. Feugier, P. Trouillas, J.-C. Froment, and N. Nighoghossian Vasodilatory Response of Border Zones to Acetazolamide Before and After Endarterectomy : An Echo Planar Imaging-Dynamic Susceptibility Contrast-Enhanced MRI Study in Patients With High-Grade Unilateral Internal Carotid Artery Stenosis Stroke, July 1, 2000; 31(7): 1561 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maeda, W. T. C. Yuh, T. Ueda, J. E. Maley, D. L. Crosby, M.-W. Zhu, and V. A. Magnotta Severe Occlusive Carotid Artery Disease: Hemodynamic Assessment by MR Perfusion Imaging in Symptomatic Patients AJNR Am. J. Neuroradiol., January 1, 1999; 20(1): 43 - 51. [Abstract] [Full Text] |
||||
![]() |
B. M. Eicke, E. Buss, R. R. Bahr, G. Hajak, and W. Paulus Influence of Acetazolamide and CO2 on Extracranial Flow Volume and Intracranial Blood Flow Velocity Stroke, January 1, 1999; 30(1): 76 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakashita, M. Kanai, T. Sugimoto, S. Taki, and M. Takamori Changes in cerebral blood flow and vasoreactivity in response to acetazolamide in patients with transient global amnesia J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 605 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Isaka, K. Nagano, M. Narita, K. Ashida, and M. Imaizumi High Signal Intensity on T2-Weighted Magnetic Resonance Imaging and Cerebral Hemodynamic Reserve in Carotid Occlusive Disease Stroke, February 1, 1997; 28(2): 354 - 357. [Abstract] [Full Text] |
||||
![]() |
H. Touho, J. Karasawa, and H. Ohnishi Preoperative and Postoperative Evaluation of Cerebral Perfusion and Vasodilatory Capacity With 99mTc-HMPAO SPECT and Acetazolamide in Childhood Moyamoya Disease Stroke, February 1, 1996; 27(2): 282 - 289. [Abstract] [Full Text] |
||||
![]() |
M. Muller and K. Schimrigk Vasomotor Reactivity and Pattern of Collateral Blood Flow in Severe Occlusive Carotid Artery Disease Stroke, February 1, 1996; 27(2): 296 - 299. [Abstract] [Full Text] |
||||
![]() |
F. Cassot, V. Vergeur, P. Bossuet, B. Hillen, M. Zagzoule, and J.-P. Marc-Vergnes Effects of Anterior Communicating Artery Diameter on Cerebral Hemodynamics in Internal Carotid Artery Disease : A Model Study Circulation, November 15, 1995; 92(10): 3122 - 3131. [Abstract] [Full Text] |
||||
![]() |
M. Muller, M. Voges, U. Piepgras, and K. Schimrigk Assessment of Cerebral Vasomotor Reactivity by Transcranial Doppler Ultrasound and Breath-Holding : A Comparison With Acetazolamide as Vasodilatory Stimulus Stroke, January 1, 1995; 26(1): 96 - 100. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |